Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy
Clinical trial NCT00739388 · COMPLETED
Trial details
- NCT number
- NCT00739388
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2010-01-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.